Light chain (AL) Amyloidosis/Primary

BridgeBio is a biotechnology company designing transformative medicines for patients with genetic diseases and cancers with clear genetic drivers.
March being Amyloidosis Awareness Month, it's a good time to tell the story of Steven Szymanski, who, until finally diagnosed with it, was roughly as familiar with…
AL Amyloidosis and Agent Orange Veterans who develop AL amyloidosis and were exposed to Agent Orange or other herbicides during military service do not have to…
The most widely used system is the European modification of the original 3-stage Mayo 2004 system which uses Troponin T or I and NT-pro-BNP to divide patients into…
The FDA has approved daratumumab and hyaluronidase-fihj (Darzalex Faspro), a subcutaneous formulation of daratumumab, for use in combination with bortezomib,…
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food…
Join the Amyloidosis Support Groupsexternal link, opens in a new tab for a webinar on AL Light Chain Amyloidosis. Speakers will include Dr. Morie Gertzexternal link…
Mayo Clinic School of Continuous Professional Development May 23, 2021 Hilton - Mayo Clinic Area, Rochester, MN, USA Course Directors: Shaji Kumar, MDexternal…
AL amyloidosis patients often have queries about diet and nutrition - about what types of foods are best to eat or avoid, or if there are any special diets they…
Amyloidosis refers to several different types of diseases where abnormal proteins are produced. These protein fibers can attach and deposit into organs, tissues,…